The role of DT-diaphorase in determining the sensitivity of human tumor cells to tirapazamine (SR 4233)

International Journal of Radiation Oncology, Biology, Physics

Volumn 29, Issue 2, 1994, Pages 369-372

  Patterson, Adam V ^a,b   Robertson, Naomi ^a   Houlbrook, Susan ^a,b   Stephens, Miriam A ^a   Adams, Gerald E ^a   Harris, Adrian L ^b   Stratford, Ian J ^a   Carmichael, James ^c  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

DT diaphorase; Human tumor cells; Tirapazamine

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TETRAZOLIUM; TIRAPAZAMINE;

BREAST CANCER; CANCER CELL CULTURE; CELL HYPOXIA; CELL LYSATE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CYTOTOXICITY; DRUG EXPOSURE; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; HUMAN; NAD(P)H DEHYDROGENASE (QUINONE); RADIATION-SENSITIZING AGENTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRAZOLIUM SALTS; THIAZOLES; TRIAZINES; TUMOR CELLS, CULTURED;

EID: 0028282995     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(94)90291-7     Document Type: Article

References (22)

1. Metabolism of SR 4233 by chinese hamster ovary cells: Basis of selective hypoxic cytotoxicity
2. The differences in kinetics of rat and human DT-diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-YL)-2,4-dinitrobenzamide)
3. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing
4. In vitro hepatotoxicity of SR 4233 (3-amino-1,2,4-benzotriazine-1,4-oxide), a hypoxic cytotoxin and potential antitumor agent
5. High levels of expression of the NAD(P)H:(quinone acceptor) oxidoreductase (NQO 1) gene in tumor cells compared to normal cells of the same origin
6. Differential modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-oestrogens and their major metabolites
7. Molecular mechanisms for the hypoxia-dependent activation of 3amino- 1,2,4-benzotriazine-1,4-dioxide
8. Microsomal reduction of 3-amino1,2,4-benzotriazine-1,4-di-N-oxide to a free radical
9. Elevated DT-diaphorase activity and messenger RNA content in human nonsmall cell lung carcinoma: Relationship to the response of lung tumor xenografts to mitomycin C
10. Initial characterization of the major mouse cytochrome P450 enzymes involved in the reductive metabolism of the hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide
11. Enzymology of the reduction of the potent benzotriazine-di-N-oxide hypoxic cell cytotoxin SR4233 by NAD(P)H:(quinone acceptor) oxidoreductase purified from Walker 256 rat tumor cells
12. DT-diaphorase and cancer chemotherapy
13. Cytosolic NAD(P)H:(quinone acceptor) oxide reductase in human normal and tumor tissue. Effects of cigarette smoking and alcohol
14. The use of DT-diaphorase for the detection of foci of early neoplastic transformation in rat liver
15. The differential hypoxic toxicity of bioreductive agents determined in vitro using the MTT assay
16. Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxins
17. Enzymology of the reductive bioactivation of SR4233: A novel benzotriazine-di-N-oxide hypoxic cell cytotoxin
18. The role of cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine-di-N-oxide hypoxic cytotoxin 3 amino-1,2,4-benzotriazine-1,4-dioxide (SR4233) by mouse liver
19. Metabolism of the bioreductive cytotoxin SR 4233 by tumor cells: Enzymatic studies
20. SR4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells
21. Structure-activity relationships for benzotriazine DI-N-oxides